These findings have important implications for our understanding of the AC-deficiency diseases, Farber’s disease and SMA-PME, as well as the high-dose toxicity associated with enzyme replacement therapy for acid-sphingomyelinase-deficient Niemann–Pick disease (ASMD). This evidence concerns the gene SMPD1 and proximal spinal muscular atrophy.